{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "Coronavirus", "Traditional medicines", "Treatment"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "32891290", "DateCompleted": {"Year": "2020", "Month": "09", "Day": "14"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "10"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "06", "Day": "17"}], "Language": ["eng"], "ELocationID": ["10.1016/j.ctcp.2020.101214", "S1744-3881(20)30703-9"], "Journal": {"ISSN": "1873-6947", "JournalIssue": {"Volume": "40", "PubDate": {"Year": "2020", "Month": "Aug"}}, "Title": "Complementary therapies in clinical practice", "ISOAbbreviation": "Complement Ther Clin Pract"}, "ArticleTitle": "A narrative literature review on traditional medicine options for treatment of corona virus disease 2019 (COVID-19).", "Pagination": {"StartPage": "101214", "MedlinePgn": "101214"}, "Abstract": {"AbstractText": ["Coronavirus disease 2019 (COVID-19) as a life-threatening disease is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that is accounted as global public health concern. Treatment of COVID-19 is primarily supportive and the role of antiviral agents is yet to be established. However, there are no specific anti-COVID-19 drugs and vaccine until now. This review focuses on traditional medicine such as medicinal plant extracts as promising approaches against COVID-19. Chinese, Indian and Iranian traditional medicine, suggests some herbs for prevention, treatment and rehabilitation of the diseases including COVID-19. Although, inhibition of viral replication is considered as general mechanism of herbal extracts, however some studies demonstrated that traditional herbal extracts can interact with key viral proteins which are associated with virus virulence. Chinese, Indian and Iranian traditional medicine, suggests some herbs for prevention, treatment and rehabilitation of the diseases including COVID-19. However the beneficial effects of these traditional medicines and their clinical trials remained to be known. Herein, we reviewed the latest updates on traditional medicines proposed for treatment of COVID-19."], "CopyrightInformation": "Copyright \u00a9 2020 Elsevier Ltd. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Molecular Biology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran."}], "LastName": "Mirzaie", "ForeName": "Amir", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran."}], "LastName": "Halaji", "ForeName": "Mehrdad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Halal Research Center of IRI, FDA, Tehran, Iran."}], "LastName": "Dehkordi", "ForeName": "Farhad Safarpoor", "Initials": "FS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Molecular Biology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran. Electronic address: ranjbarre@gmail.com."}], "LastName": "Ranjbar", "ForeName": "Reza", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran."}], "LastName": "Noorbazargan", "ForeName": "Hassan", "Initials": "H"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Complement Ther Clin Pract", "NlmUniqueID": "101225531", "ISSNLinking": "1744-3881"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Betacoronavirus"}, {"QualifierName": [], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "China"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Coronavirus Infections"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "India"}, {"QualifierName": [], "DescriptorName": "Iran"}, {"QualifierName": [], "DescriptorName": "Pandemics"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Pneumonia, Viral"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Guo Y.-R., Cao Q.-D., Hong Z.-S., Tan Y.-Y., Chen S.-D., Jin H.-J., Tan K.-S., Wang D.-Y., Yan Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak\u2013an update on the status. Mil. Med. Res. 2020;7(1):1\u201310.", "ArticleIdList": ["PMC7068984", "32169119"]}, {"Citation": "C.t.n.N.f.C.F.a.a.N.-a.I.i.C.-T.S.-C.a. ClinicalTrials.gov."}, {"Citation": "Halaji M., Farahani A., Ranjbar R., Heiat M., SAfarpoor Dehkordi F. Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19. Infez Med. 2020;28(1):6\u201317. 2020.", "ArticleIdList": ["32532933"]}, {"Citation": "Singhal T. A review of coronavirus disease-2019 (COVID-19) Indian J. Pediatr. 2020:1\u20136.", "ArticleIdList": ["PMC7090728", "32166607"]}, {"Citation": "Numbers S.I., Assessment W.R. Coronavirus disease 2019 (COVID-19) Americas. 2020;10(2):1."}, {"Citation": "Wu J.T., Leung K., Leung G.M. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet. 2020;395(10225):689\u2013697.", "ArticleIdList": ["PMC7159271", "32014114"]}, {"Citation": "Prajapat M., Sarma P., Shekhar N., Avti P., Sinha S., Kaur H., Kumar S., Bhattacharyya A., Kumar H., Bansal S. Drug targets for corona virus: a systematic review. Indian J. Pharmacol. 2020;52(1):56.", "ArticleIdList": ["PMC7074424", "32201449"]}, {"Citation": "Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497\u2013506.", "ArticleIdList": ["PMC7159299", "31986264"]}, {"Citation": "Denaro M., Smeriglio A., Barreca D., De Francesco C., Occhiuto C., Milano G., Trombetta D. Antiviral activity of plants and their isolated bioactive compounds: an update. Phytother Res. 2020;34(4):742\u2013768.", "ArticleIdList": ["31858645"]}, {"Citation": "Oyero O.G., Toyama M., Mitsuhiro N., Onifade A.A., Hidaka A., Okamoto M., Baba M. Selective inhibition of hepatitis c virus replication by Alpha-zam, a Nigella sativa seed formulation. Afr. J. Tradit., Complementary Altern. Med. 2016;13(6):144\u2013148.", "ArticleIdList": ["PMC5412185", "28480371"]}, {"Citation": "Cui H.-T., Li Y.-T., Guo L.-Y., Liu X.-G., Wang L.-S., Jia J.-W., Liao J.-B., Miao J., Zhang Z.-Y., Wang L. Traditional Chinese medicine for treatment of coronavirus disease 2019: a review. Tradit. Med. Res. 2020;5(2):65\u201373."}, {"Citation": "Zumla A., Chan J.F., Azhar E.I., Hui D.S., Yuen K.-Y. Coronaviruses\u2014drug discovery and therapeutic options. Nat. Rev. Drug Discov. 2016;15(5):327.", "ArticleIdList": ["PMC7097181", "26868298"]}, {"Citation": "Tong X., Li A., Zhang Z., Duan J., Chen X., Hua C., Zhao D., Xu Y., Shi X., Li P. TCM treatment of infectious atypical pneumonia--a report of 16 cases. J. Tradit. Chin. Med. 2004;24(4):266\u2013269. Chung i tsa chih ying wen pan.", "ArticleIdList": ["15688692"]}, {"Citation": "Li X., Zhang X., Ding J., Xu Y., Wei D., Tian Y., Chen W., Huang J., Wen T., Li S. 2014. Comparison between Chinese Herbal Medicines and Conventional Therapy in the Treatment of Severe Hand, Foot, and Mouth Disease: a Randomized Controlled Trial, Evidence-Based Complementary and Alternative Medicine 2014.", "ArticleIdList": ["PMC3955630", "24719639"]}, {"Citation": "Zhang M.-M., Liu X.-M., He L. Effect of integrated traditional Chinese and Western medicine on SARS: a review of clinical evidence. World J. Gastroenterol.: WJG. 2004;10(23):3500.", "ArticleIdList": ["PMC4576235", "15526373"]}, {"Citation": "Vellingiri B., Jayaramayya K., Iyer M., Narayanasamy A., Govindasamy V., Giridharan B., Ganesan S., Venugopal A., Venkatesan D., Ganesan H. COVID-19: a promising cure for the global panic. Sci. Total Environ. 2020:138277.", "ArticleIdList": ["PMC7128376", "32278175"]}, {"Citation": "Balachandar V., Mahalaxmi I., Kaavya J., Vivekanandhan G., Ajithkumar S., Arul N., Singaravelu G., Kumar N.S., Devi S.M. COVID-19: emerging protective measures. Eur. Rev. Med. Pharmacol. Sci. 2020;24(6):3422\u20133425.", "ArticleIdList": ["32271461"]}, {"Citation": "Jiang F., Deng L., Zhang L., Cai Y., Cheung C.W., Xia Z. Review of the clinical characteristics of coronavirus disease 2019 (COVID-19) J. Gen. Intern. Med. 2020:1\u20135.", "ArticleIdList": ["PMC7088708", "32133578"]}, {"Citation": "Mohammadpour S., Torshizi Esfahani A., Halaji M., Lak M., Ranjbar R. An updated review of the association of host genetic factors with susceptibility and resistance to COVID-19. J Cell Physiol. 2020:1\u20136. doi: 10.1002/jcp.29868.", "ArticleIdList": ["10.1002/jcp.29868", "PMC7323230", "32542735"]}, {"Citation": "Aldridge M. 2020. Review of the Antiviral Activity and Pharmacology of Monoglycerides and Implications for Treatment of COVID-19."}, {"Citation": "Y. Liu, C. Zhang, F. Huang, Y. Yang, F. Wang, J. Yuan, Z. Zhang, Y. Qin, X. Li, D. Zhao, Elevated plasma level of selective cytokines in COVID-19 patients reflect viral load and lung injury. 2020. DOI: 10.31219/osf.io/qdsef.", "ArticleIdList": ["PMC7107806", "34676126"]}, {"Citation": "Brogna C. 2020. The\" Zero Point\" and the Autonomous Nervous System. Reverse Analysis, Syllogism and Genetic. Possible Correlations with the Covid19 Virus. A New Perspective."}, {"Citation": "Organization W.H. World Health Organization; 2020. Modes of Transmission of Virus Causing COVID-19: Implications for IPC Precaution Recommendations: Scientific Brief, 27 March 2020."}, {"Citation": "Yuen K.-S., Ye Z.-W., Fung S.-Y., Chan C.-P., Jin D.-Y. SARS-CoV-2 and COVID-19: the most important research questions. Cell Biosci. 2020;10(1):1\u20135.", "ArticleIdList": ["PMC7074995", "32190290"]}, {"Citation": "Hindson J. COVID-19: faecal\u2013oral transmission? Nat. Rev. Gastroenterol. Hepatol. 2020;17(5) 259-259.", "ArticleIdList": ["PMC7095230", "32214231"]}, {"Citation": "Tahamtan A., Ardebili A. Taylor & Francis; 2020. Real-time RT-PCR in COVID-19 Detection: Issues Affecting the Results.", "ArticleIdList": ["PMC7189409", "32297805"]}, {"Citation": "Li G., Zhao J., Tu Z., Li J., Liu Q., Shi L., Miao Q., Yuan H., Liu X., Long Y. Treating influenza patients of wind-heat affecting Fei syndrome by jinhua qinggan granule: a double-blinded randomized control trial. Chin. J. Integr. Tradit. West. Med. 2013;33(12):1631\u20131635. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi.", "ArticleIdList": ["24517059"]}, {"Citation": "Li H., Liu S.-M., Yu X.-H., Tang S.-L., Tang C.-K. Coronavirus disease 2019 (COVID-19): current status and future perspective. Int. J. Antimicrob. Agents. 2020:105951.", "ArticleIdList": ["PMC7139247", "32234466"]}, {"Citation": "Cao B., Wang Y., Wen D., Liu W., Wang J., Fan G., Ruan L., Song B., Cai Y., Wei M. A trial of lopinavir\u2013ritonavir in adults hospitalized with severe Covid-19. N. Engl. J. Med. 2020", "ArticleIdList": ["PMC7121492", "32187464"]}, {"Citation": "Stower H. Lopinavir\u2013ritonavir in severe COVID-19. Nat. Med. 2020;26(4) 465-465.", "ArticleIdList": ["32273604"]}, {"Citation": "Liu J., Cao R., Xu M., Wang X., Zhang H., Hu H., Li Y., Hu Z., Zhong W., Wang M. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discov. 2020;6(1):1\u20134.", "ArticleIdList": ["PMC7078228", "32194981"]}, {"Citation": "Agostini M.L., Andres E.L., Sims A.C., Graham R.L., Sheahan T.P., Lu X., Smith E.C., Case J.B., Feng J.Y., Jordan R. Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease. mBio. 2018;9(2) e00221-18.", "ArticleIdList": ["PMC5844999", "29511076"]}, {"Citation": "Yethindra V. Role of GS-5734 (Remdesivir) in inhibiting SARS-CoV and MERS-CoV: the expected role of GS-5734 (Remdesivir) in COVID-19 (2019-nCoV)-VYTR hypothesis. Int. J. Res. Pharm. Sci. 2020;11(SPL1):1\u20136."}, {"Citation": "Cao Y.-c., Deng Q.-x., Dai S.-x. Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: an evaluation of the evidence. Trav. Med. Infect. Dis. 2020:101647.", "ArticleIdList": ["PMC7151266", "32247927"]}, {"Citation": "Tu Y.-F., Chien C.-S., Yarmishyn A.A., Lin Y.-Y., Luo Y.-H., Lin Y.-T., Lai W.-Y., Yang D.-M., Chou S.-J., Yang Y.-P. A review of SARS-CoV-2 and the ongoing clinical trials. Int. J. Mol. Sci. 2020;21(7):2657.", "ArticleIdList": ["PMC7177898", "32290293"]}, {"Citation": "Yao X., Ye F., Zhang M., Cui C., Huang B., Niu P., Liu X., Zhao L., Dong E., Song C. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Clin Infect Dis. 2020 doi: 10.1093/cid/ciaa237.", "ArticleIdList": ["10.1093/cid/ciaa237", "PMC7108130", "32150618"]}, {"Citation": "Li L., Li R., Wu Z., Yang X., Zhao M., Liu J., Chen D. Therapeutic strategies for critically ill patients with COVID-19. Ann. Intensive Care. 2020;10:1\u20139.", "ArticleIdList": ["PMC7167303", "32307593"]}, {"Citation": "Li C., Bo L., Liu Q., Jin F. Thymosin alpha1 based immunomodulatory therapy for sepsis: a systematic review and meta-analysis. Int. J. Infect. Dis. 2015;33:90\u201396.", "ArticleIdList": ["25532482"]}, {"Citation": "Bloch E.M., Shoham S., Casadevall A., Sachais B.S., Shaz B., Winters J.L., van Buskirk C., Grossman B.J., Joyner M., Henderson J.P. Deployment of convalescent plasma for the prevention and treatment of COVID-19. J Clin Invest. 2020;130(6):2757\u20132765. doi: 10.1172/JCI138745.", "ArticleIdList": ["10.1172/JCI138745", "PMC7259988", "32254064"]}, {"Citation": "Shanmugaraj B., Siriwattananon K., Wangkanont K., Phoolcharoen W. Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19) Asian Pac. J. Allergy Immunol. 2020;38(1):10\u201318.", "ArticleIdList": ["32134278"]}, {"Citation": "Lythgoe M.P., Middleton P. Ongoing clinical trials for the management of the COVID-19 pandemic. Trends Pharmacol. Sci. 2020;41(6):363\u2013382. doi: 10.1016/j.tips.2020.03.006.", "ArticleIdList": ["10.1016/j.tips.2020.03.006", "PMC7144665", "32291112"]}, {"Citation": "Sheikhshahrokh A., Ranjbar R., Saeidi E., Dehkordi F.S., Heiat M., Ghasemi-Dehkordi P., Goodarzi H. Frontier therapeutics and vaccine strategies for SARS-CoV-2 (COVID-19): a review. Iran. J. Public Health. 2020;49:18\u201329.", "ArticleIdList": ["PMC8266011", "34268202"]}, {"Citation": "Hung I.F., To K.K., Lee C.-K., Lee K.-L., Chan K., Yan W.-W., Liu R., Watt C.-L., Chan W.-M., Lai K.-Y. Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection. Clin. Infect. Dis. 2011;52(4):447\u2013456.", "ArticleIdList": ["PMC7531589", "21248066"]}, {"Citation": "Khan S., Kazmi A., Bashir N., Siddique R. COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. J. Adv. Res. 2020;16:91\u201398. doi: 10.1016/j.jare.2020.03.005.", "ArticleIdList": ["10.1016/j.jare.2020.03.005", "PMC7113610", "32257431"]}, {"Citation": "Hong-Zhi D., Xiao-Ying H., Yu-Huan M., Huang B.-S., Da-Hui L. Traditional Chinese Medicine: an effective treatment for 2019 novel coronavirus pneumonia (NCP) Chin. J. Nat. Med. 2020;18(3):206\u2013210.", "ArticleIdList": ["PMC7270732", "32245590"]}, {"Citation": "Chen H., Guo J., Wang C., Luo F., Yu X., Zhang W., Li J., Zhao D., Xu D., Gong Q. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020;395(10226):809\u2013815.", "ArticleIdList": ["PMC7159281", "32151335"]}, {"Citation": "Chen L., Xiong J., Bao L., Shi Y. Convalescent plasma as a potential therapy for COVID-19. Lancet Infect. Dis. 2020;20(4):398\u2013400.", "ArticleIdList": ["PMC7128218", "32113510"]}, {"Citation": "E.J. Giamarellos-Bourboulis, Efficiency in Management of Organ Dysfunction Associated with Infection by the Novel Sars-Cov-2 Virus (COVID-19) through A Personalized Immunotherapy Approach: the Escape Clinical TriaL."}, {"Citation": "Chinnasamy N., Harishankar N., Kumar P.U., Rukmini C. Toxicological studies on debitterized neem oil (Azadirachta indica) Food Chem. Toxicol. 1993;31(4):297\u2013301.", "ArticleIdList": ["8477918"]}, {"Citation": "Greig A., Bouillant A. Binding effects of concanavalin A on a coronavirus. Can. J. Comp. Med. 1977;41(1):122.", "ArticleIdList": ["PMC1277703", "832184"]}, {"Citation": "Li S.-y., Chen C., Zhang H.-q., Guo H.-y., Wang H., Wang L., Zhang X., Hua S.-n., Yu J., Xiao P.-g. Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antivir. Res. 2005;67(1):18\u201323.", "ArticleIdList": ["PMC7114104", "15885816"]}, {"Citation": "Lau K.-M., Lee K.-M., Koon C.-M., Cheung C.S.-F., Lau C.-P., Ho H.-M., Lee M.Y.-H., Au S.W.-N., Cheng C.H.-K., Bik-San Lau C. Immunomodulatory and anti-SARS activities of Houttuynia cordata. J. Ethnopharmacol. 2008;118(1):79\u201385.", "ArticleIdList": ["PMC7126383", "18479853"]}, {"Citation": "Luo Y., Wang C.-Z., Hesse-Fong J., Lin J.-G., Yuan C.-S. Application of Chinese medicine in acute and critical medical conditions. Am. J. Chin. Med. 2019;47(6):1223\u20131235.", "ArticleIdList": ["31505937"]}, {"Citation": "Chiow K., Phoon M., Putti T., Tan B.K., Chow V.T. Evaluation of antiviral activities of Houttuynia cordata Thunb. extract, quercetin, quercetrin and cinanserin on murine coronavirus and dengue virus infection. Asian Pac. J. Trop. Med. 2016;9(1):1\u20137.", "ArticleIdList": ["PMC7104935", "26851778"]}, {"Citation": "Ho T.-Y., Wu S.-L., Chen J.-C., Li C.-C., Hsiang C.-Y. Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction. Antivir. Res. 2007;74(2):92\u2013101.", "ArticleIdList": ["PMC7114332", "16730806"]}, {"Citation": "Wen C.-C., Shyur L.-F., Jan J.-T., Liang P.-H., Kuo C.-J., Arulselvan P., Wu J.-B., Kuo S.-C., Yang N.-S. Traditional Chinese medicine herbal extracts of Cibotium barometz, Gentiana scabra, Dioscorea batatas, Cassia tora, and Taxillus chinensis inhibit SARS-CoV replication. Tradit. Complement. Med. 2011;1(1):41\u201350.", "ArticleIdList": ["PMC3942999", "24716104"]}, {"Citation": "Ulasli M., Gurses S.A., Bayraktar R., Yumrutas O., Oztuzcu S., Igci M., Igci Y.Z., Cakmak E.A., Arslan A. The effects of Nigella sativa (Ns), Anthemis hyalina (Ah) and Citrus sinensis (Cs) extracts on the replication of coronavirus and the expression of TRP genes family. Mol. Biol. Rep. 2014;41(3):1703\u20131711.", "ArticleIdList": ["PMC3933739", "24413991"]}, {"Citation": "Zhang C.-H., Wang Y.-F., Liu X.-j., Lu J.-H., Qian C.-w., Wan Z.-y., Yan X.-g., Zheng H.-y., Zhang M.-Y., Xiong S. Antiviral activity of cepharanthine against severe acute respiratory syndrome coronavirus in vitro. Chin. Med. J. 2005;118(6):493.", "ArticleIdList": ["15788131"]}, {"Citation": "Yang C.-W., Lee Y.-Z., Kang I.-J., Barnard D.L., Jan J.-T., Lin D., Huang C.-W., Yeh T.-K., Chao Y.-S., Lee S.-J. Identification of phenanthroindolizines and phenanthroquinolizidines as novel potent anti-coronaviral agents for porcine enteropathogenic coronavirus transmissible gastroenteritis virus and human severe acute respiratory syndrome coronavirus. Antivir. Res. 2010;88(2):160\u2013168.", "ArticleIdList": ["PMC7114283", "20727913"]}, {"Citation": "Korytkowski M., Bell D., Jacobsen C., Suwannasari R., Team F.S. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus. Clin. Therapeut. 2003;25(11):2836\u20132848.", "ArticleIdList": ["14693308"]}, {"Citation": "Yang R., Liu H., Bai C., Wang Y., Zhang X., Guo R., Wu S., Wang J., Leung E., Chang H. Chemical composition and pharmacological mechanism of qingfei paidu decoction and Ma Xing Shi Gan decoction against coronavirus disease 2019 (COVID-19): in silico and experimental study. Pharmacol. Res. 2020:104820.", "ArticleIdList": ["PMC7194979", "32360484"]}, {"Citation": "Xu J., Zhang Y. Traditional Chinese medicine treatment of COVID-19, complementary therapies in clinical practice. 2020;39:101165.", "ArticleIdList": ["PMC7118627", "32379692"]}, {"Citation": "Chen Z., Nakamura T. Statistical evidence for the usefulness of Chinese medicine in the treatment of SARS. Phytother Res. 2004;18(7):592\u2013594. An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives.", "ArticleIdList": ["15305324"]}, {"Citation": "Li Y., Liu X., Guo L., Li J., Zhong D., Zhang Y., Clarke M., Jin R. Traditional Chinese herbal medicine for treating novel coronavirus (COVID-19) pneumonia: protocol for a systematic review and meta-analysis. Syst. Rev. 2020;9:1\u20136.", "ArticleIdList": ["PMC7138957", "32268923"]}, {"Citation": "Yangxin S. Summary report on Lianhua Qingwen capsule/granule for the treatment of influenza. Cold Coronavirus Dis. 2019 http://en.yiling.cn/ylen/contents/2204/226.html (COVID-19), (2020) Submitted for publication."}, {"Citation": "Fang Y.-C., Huang H.-C., Chen H.-H., Juan H.-F. TCMGeneDIT: a database for associated traditional Chinese medicine, gene and disease information using text mining. BMC Compl. Alternative Med. 2008;8(1):1\u201311.", "ArticleIdList": ["PMC2584015", "18854039"]}, {"Citation": "Yang Y., Islam M.S., Wang J., Li Y., Chen X. Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): a review and perspective. Int. J. Biol. Sci. 2020;16(10):1708.", "ArticleIdList": ["PMC7098036", "32226288"]}, {"Citation": "Kim H.-Y., Shin H.-S., Park H., Kim Y.-C., Yun Y.G., Park S., Shin H.-J., Kim K. In vitro inhibition of coronavirus replications by the traditionally used medicinal herbal extracts, Cimicifuga rhizoma, Meliae cortex, Coptidis rhizoma, and Phellodendron cortex. J. Clin. Virol. 2008;41(2):122\u2013128.", "ArticleIdList": ["PMC7108295", "18036887"]}, {"Citation": "Zhang K. Is traditional Chinese medicine useful in the treatment of COVID-19? Am. J. Emerg. Med. 2020 doi: 10.1016/j.ajem.2020.03.046. In press.", "ArticleIdList": ["10.1016/j.ajem.2020.03.046", "PMC7138187", "32245701"]}, {"Citation": "Qu D., Zheng B., Yao X., Guan Y., Yuan Z.-H., Zhong N.-S., Lu L.-W., Xie J.-P., Wen Y.-M. Intranasal immunization with inactivated SARS-CoV (SARS-associated coronavirus) induced local and serum antibodies in mice. Vaccine. 2005;23(7):924\u2013931.", "ArticleIdList": ["PMC7115388", "15603894"]}, {"Citation": "Wang L.-s., Wang Y.-r., Ye D.-w., Liu Q.-q. A review of the 2019 Novel Coronavirus (COVID-19) based on current evidence. Int. J. Antimicrob. Agents. 2020:105948.", "ArticleIdList": ["PMC7156162", "32201353"]}, {"Citation": "Gomathi M., Padmapriya S., Balachandar V. Drug studies on Rett syndrome: from bench to bedside. J. Autism Dev. Disord. 2020:1\u201325.", "ArticleIdList": ["32016693"]}, {"Citation": "Vimalanathan S., Ignacimuthu S., Hudson J. Medicinal plants of Tamil Nadu (Southern India) are a rich source of antiviral activities. Pharmaceut. Biol. 2009;47(5):422\u2013429."}, {"Citation": "Tiwari B.K., Khosa R. Hepatoprotective and antioxidant effect of Sphaeranthus indicus against acetaminophen-induced hepatotoxicity in rats. J. Pharmaceut. Sci. Res. 2009;1(2):26\u201330."}, {"Citation": "Keyaerts E., Vijgen L., Maes P., Neyts J., Van Ranst M. In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine. Biochem. Biophys. Res. Commun. 2004;323(1):264\u2013268.", "ArticleIdList": ["PMC7092815", "15351731"]}, {"Citation": "Hussain F., Jahan N., Rahman K.-u., Sultana B., Jamil S. 2018. Identification of Hypotensive Biofunctional Compounds of Coriandrum Sativum and Evaluation of Their Angiotensin-Converting Enzyme (ACE) Inhibition Potential, Oxidative Medicine and Cellular Longevity 2018.", "ArticleIdList": ["PMC6276458", "30581531"]}, {"Citation": "Otake T., Mori H., Morimoto M., Ueba N., Sutardjo S., Kusumoto I.T., Hattori M., Namba T. Screening of Indonesian plant extracts for anti\u2010human immunodeficiency virus\u2014type 1 (HIV\u20101) activity. Phytother Res. 1995;9(1):6\u201310."}, {"Citation": "Yu Y.-B. The Extracts of Solanum nigrum L. for inhibitory effects on HIV-1 and its essential enzymes. Kor. J. Orient. Med. 2004;10(1):119\u2013126."}, {"Citation": "Ganjhu R.K., Mudgal P.P., Maity H., Dowarha D., Devadiga S., Nag S., Arunkumar G. Herbal plants and plant preparations as remedial approach for viral diseases. Virus Dis. 2015;26(4):225\u2013236.", "ArticleIdList": ["PMC4663710", "26645032"]}, {"Citation": "Ziai S., Heidari M. Inhibitory effects of germinal angiotensin converting enzyme by medicinal plants used in Iranian traditional medicine as antihypertensive. J. Kerman Univ. Med. Sci. 2015;16(2):134\u2013144."}, {"Citation": "Lee S.H., Chung N., Kwan J., Kim D.-I., Kim W.H., Kim C.J., Kim H.S., Park S.H., Seo H.S., Shin D.G. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia. Clin. Therapeut. 2007;29(11):2365\u20132373.", "ArticleIdList": ["18158077"]}, {"Citation": "Koch S., Pong W. vol. 20. BioCentury Inc.; 2020. (First up for COVID-19: Nearly 30 Clinical Readouts before End of April). March."}, {"Citation": "van der Hoek L., Sure K., Ihorst G., Stang A., Pyrc K., Jebbink M.F., Petersen G., Forster J., Berkhout B., \u00dcberla K. Croup is associated with the novel coronavirus NL63. PLoS Med. 2005;2(8)", "ArticleIdList": ["PMC1188248", "16104827"]}, {"Citation": "Gautret P., Lagier J.-C., Parola P., Meddeb L., Sevestre J., Mailhe M., Doudier B., Aubry C., Amrane S., Seng P. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: a pilot observational study. Trav. Med. Infect. Dis. 2020:101663.", "ArticleIdList": ["PMC7151271", "32289548"]}, {"Citation": "Clinical trial number NCT04317040 for \"CD24Fc as a non-antiviral immunomodulator in COVID-19 treatment (SAC-COVID)\" (at ClinicalTrials.gov)."}, {"Citation": "McGrath J., April All the COVID-19 vaccines and treatments currently in clinical trials. Digit. Trends. 2020 https://www.digitaltrends.com/health-fitness/coronavirus-covid-19-vaccines-treatments-list/ Retrieved 6 April 2020."}, {"Citation": "Clinical trial number NCT04350593 for \"Dapagliflozin in respiratory failure in patients with COVID-19 (DARE-19)\" (at ClinicalTrials.gov)."}, {"Citation": "Koch S., Pong W. BioCentury Inc; 13 March 2020. First up for COVID-19: Nearly 30 Clinical Readouts before End of April. Retrieved 1 April 2020."}, {"Citation": "COVID-19 Treatment Tracker (Updated 2-3x/week) Milken Institute; 2020-05-05. Retrieved 2020-05-07."}, {"Citation": "Staines R. PharmaPhorum; 31 March 2020. Sanofi Begins Trial of Kevzara against COVID-19 Complications. Retrieved 6 April 2020."}, {"Citation": "COVID-19 Treatment Tracker (Updated 2-3x/week) Milken Institute; 2020-05-05. Retrieved 2020-05-07."}, {"Citation": "Clinical trial number NCT04351152 for \"phase 3 study to evaluate efficacy and safety of lenzilumab in hospitalized patients with COVID-19 pneumonia\" (at ClinicalTrials.gov)."}, {"Citation": "Koch S., Pong W. BioCentury Inc; 13 March 2020. First up for COVID-19: Nearly 30 Clinical Readouts before End of April. Retrieved 1 April 2020."}, {"Citation": "Rosa S.G.V., Santos W.C. Clinical trials on drug repositioning for COVID-19 treatment. Rev. Panam. Salud P\u00fablic. 2020;44", "ArticleIdList": ["PMC7105280", "32256547"]}, {"Citation": "Uyeki T.M. Oxford University Press US; 2018. Oseltamivir Treatment of Influenza in Children.", "ArticleIdList": ["PMC6669028", "29315362"]}, {"Citation": "Kashiouris M.G., L'Heureux M., Cable C.A., Fisher B.J., Leichtle S.W. The emerging role of vitamin C as a treatment for sepsis. Nutrients. 2020;12(2):292.", "ArticleIdList": ["PMC7070236", "31978969"]}, {"Citation": "Wang Y., Fei D., Vanderlaan M., Song A. Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitro. Angiogenesis. 2004;7(4):335\u2013345.", "ArticleIdList": ["15886877"]}, {"Citation": "Markham A., Keam S.J. Danoprevir: first global approval. Drugs. 2018;78(12):1271\u20131276.", "ArticleIdList": ["30117020"]}, {"Citation": "Dyer O. Two Ebola treatments halve deaths in trial in DRC outbreak. BMJ Br. Med. J. (Clin. Res. Ed.) 2019;366", "ArticleIdList": ["31409588"]}, {"Citation": "Wang Y., Xiao J., Suzek T.O., Zhang J., Wang J., Bryant S.H. PubChem: a public information system for analyzing bioactivities of small molecules. Nucleic Acids Res. 2009;37(suppl_2):W623\u2013W633.", "ArticleIdList": ["PMC2703903", "19498078"]}, {"Citation": "Zong Y., Ding M.L., Jia K.K., Ma S.T., Ju W.Z. Exploring active compounds of Da-Yuan-Yin in treatment of COVID-19 based on network pharmacology and molecular docking method. Chin. Tradit. Herb. Drugs. 2020;51(4)"}, {"Citation": "Ren J.-l., Zhang A.-H., Wang X.-J. Traditional Chinese medicine for COVID-19 treatment. Pharmacol. Res. 2020;155:104743.", "ArticleIdList": ["PMC7128263", "32145402"]}, {"Citation": "Sterne J.A., Hern\u00e1n M.A., Reeves B.C., Savovi\u0107 J., Berkman N.D., Viswanathan M., Henry D., Altman D.G., Ansari M.T., Boutron I., Robins -I. A tool for assessing risk of bias in non-randomised studies of interventions. Br. Med. J. 2016;355:i4919.", "ArticleIdList": ["PMC5062054", "27733354"]}, {"Citation": "Jiang W., Shen Q., Chen M., Wang Y., Zhou Q., Zhu X., Zhu X. Levonorgestrel-releasing intrauterine system use in premenopausal women with symptomatic uterine leiomyoma: a systematic review. Steroids. 2014;86:69\u201378.", "ArticleIdList": ["24832215"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "5", "Day": "12"}, {"Year": "2020", "Month": "6", "Day": "8"}, {"Year": "2020", "Month": "6", "Day": "15"}, {"Year": "2020", "Month": "9", "Day": "6", "Hour": "20", "Minute": "20"}, {"Year": "2020", "Month": "9", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "9", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "6", "Day": "17"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32891290", "PMC7831809", "10.1016/j.ctcp.2020.101214", "S1744-3881(20)30703-9"]}}], "PubmedBookArticle": []}